Company
Hemogenyx Pharmaceuticals PLC
LON:HEMO
Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
128 stories · page 1 of 2
Investments and investor services
Hemogenyx Pharmaceuticals making pleasing progress
"The board is very pleased with the progress being made with the unlocking of additional opportunities for the CDX antibodies, as well as the potential value that can be created through the company's updated humanised mouse model,” said cha
Hemogenyx Pharmaceuticals PLC advisory board member recognised for breast cancer breakthrough
H. Michael Shepard’s ground-breaking work on the discovery of Herceptin, the now widely-prescribed breast cancer drug, has been acknowledged with the 2019 Lasker-DeBakey Clinical Medical Research Award
Archive
Proactive news snapshot: Faron Pharmaceuticals, Pan African Resources, Iofina, Open Orphan …
A glance at some of the day's highlights from the Proactive Investors newswire
Hemogenyx files new patent application for CDX technology
The application covers the antibody's use in conditioning patients for bone marrow transplant and its deployment in a number of hard-to-treat blood borne diseases, including acute myeloid leukaemia
Investments and investor services
FTSE 100 closes lower Friday after lacklustre week
The FTSE 250 went the other way and gained over 87 points on Friday
Investments and investor services
FTSE 100 closes higher on day and week as world leaders meet
The mid-cap FTSE 250 added over 147 points to close at 19,462 on Friday
Archive
City’s eyes turn to G20 summit on quiet Friday in London
With little company news due on Friday, investors will instead be looking to the latest G20 summit in Osaka, Japan
Archive
Proactive news snapshot: Kibo Energy, CentralNic, OptiBiotix Health...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Hemogenyx develops new mouse model which could play a big role in future wars
Hemogenyx thinks its new ApbHC mouse model could be used to rapidly develop antibodies to treat deadly pathogens such as Anthrax released as an act of war
Archive
News from FirstGroup, Stagecoach to drive corporate diary in coming week
Aside from the two mid-cap transport operators, blue chip contractor Bunzl will also issue a trading update, while the macro focus will be on the G20 meeting in Japan
Archive
Proactive news snapshot: Taptica, HemoGenyx Pharmaceuticals, IronRidge Resources, Sirius Minerals…
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Techfinancials surges on blockchain hopes despite patchy trading update
A look at the day's major movers, including Big Sofa Technologies, Techfinancials, Paragon Entertainment, Pendragon, Metro Bank, Serco, Taptica, HemoGenyx Pharmaceuticals ...
Investments and investor services
Hemogenyx reports encouraging data for bone marrow transplant therapy
"This new data demonstrates our continuing progress in developing potential uses for our CDX antibody.”
Archive
FTSE 100 closes in the red as global equity markets lag
The UK's premier shares index finished the afternoon session off nearly 31 points at 7,367
Archive
Proactive news snapshot: Hemogenyx Pharmaceuticals, Bacanora Lithium, Arc Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Go-Ahead tracks up as it makes interim CFO permanent
A look at some of the biggest risers and fallers in London on Wednesday
Investments and investor services
Hemogenyx soars as CDX antibody demonstrates effectiveness against acute myeloid leukemia
Vladislav Sandler, the company’s chief executive, said the firm was “encouraged” by the results
Investments and investor services
FTSE 100 closes near flat as US ADP jobs report shakes confidence
The UK blue-chip share index finished up around four points at 7,218
Investments and investor services
Immotion commotion as it signs virtual reality deal with a Florida zoo
A look at the day's major movers, including Aptitude Software, Watches of Switzerland, Veltyco, Johnson Matthey, Nuformix, HemoGenyx, De La Rue and Real Good Food
Archive
Proactive news snapshot: HemoGenyx Pharmaceuticals, Cadogan Petroleum, BigDish …
A glance at some of the day's highlights from the Proactive Investors newswire
Hemogenyx Pharmaceuticals delivers encouraging data on antibody drug candidate
“This antibody should, if successful, provide a new and potentially effective treatment for a form of blood cancer for which adult survival rates are currently very poor," said CEO Vladislav Sandler
Investments and investor services
FTSE 100 regains ground at the close
The FTSE 100 closed 32.86 points higher at 7,218.16 on Thursday, just easing off its late afternoon high of 7,235
Archive
Proactive news snapshot: Sirius Minerals, Motif Bio, ECR Minerals, TLOU Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Hemogenyx says progress continuing towards Investigational New Drug submission for CDX antibody
The AIM-listed group last year signed an agreement with a global bio-pharmaceutical company to develop its CDX antibodies under a potential for licensing deal
Archive
Proactive news snapshot: Xpediator, Kibo Energy, Mirada …
A glance at some of the day's highlights from the Proactive Investors newswire
Hemogenyx Pharma resetting the bar in blood cancers
"With multiple collaboration agreements and investment from industry we view the company as undervalued," says Northland
Archive
Argo Blockchain in demand but Mobile Streams' gains ebb away
A look at the day's major movers, including Kibo Energy, Red Rose, Red Emperor Resources, Anglo African Oil & Gas, Mobile Streams, Dunelm and Ted Baker
Archive
Proactive news snapshot: Nektan, 88 Energy, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Hemogenyx set for talks over potential licensing deal with global pharma later this month
Hemogenyx is already working with the unnamed company to further develop its CDX antibodies and it hopes to open talks over a possible licensing deal in the coming weeks
Investments and investor services
FTSE 100 closes lower after struggling to gain ground all day
The FTSE 250 on the other hand, a better gauge of UK companies, added over 180 points at 17,976
Archive
Proactive news snapshot: Oracle Power, Midatech Pharma, Block Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Curzon Energy pauses at Coos Bay to focus on partnership talks with Pared Energy
A look at the day's maor movers, including Carnival, EKF, Chamberlin, Panthera, NetScientific and Yu Group
FTSE 100 closes in the red as Federal Reserve's rate hike creates jitters
"Investors aren’t willing to forgive Fed Chair Jeremy Powell yet; a soft open on Wall Street threatens to drag the FTSE lower into the close," said Fiona Cincotta at City Index
Archive
Proactive news snapshot: Symphony Environmental Technologies, Union Jack Oil, SIMEC Atlantis ...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Oilex returns from suspension after Indian High Court issues judgement on Cambay
A look at the day's shakers and quakers, including Hiscox, Serica Energy, SIMEC Atlantis, Symphony Environmental, Kore Potash, Angus Energy and TomCo Energy
FTSE 100 closes marginally higher as European indices lag; US mid-terms in focus
FTSE 100 closed marginally higher but mid-cap cousin FTSE 250 plunged nearly ten points.
Archive
Proactive news snapshot: Hemogenyx, WideCells, Feedback, Synairgen …
A glance at some of the day's highlights from the Proactive Investors newswire
Symphony Environmental surges on UK government plastics ban plans
Some of the main news-driven risers and fallers in London on Monday …
Orgenesis to invest at least another US$1mln into Hemogenyx as part of latest collaboration deal
This time around, the investment is centred on Hemogenyx’s Hu-PHEC technology - a cell replacement product candidate that is being developed to generate cancer-free, patient-matched blood stem cells after transplantation into the patient
FTSE 100 finishes lower as trade worries rear their head again
The UK's premier index of leading shares closed down seven points, or 0.10% at 7,042
Essentra dips after mixed trading update, Dechra Pharma trots up on acquisition news
A look at some winners and losers in UK equity trading during Friday's session
Archive
Proactive news snapshot: Hemogenyx Pharmaceuticals, PhotonStar LED, Futura Medical …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Hemogenyx to receive US$1mln investment from Orgenesis as part of new collaboration deal
The biopharmas will work together to develop Hemogenyx’s AHC technology, while Orgenesis will invest at least US$1mln in Hemogenyx through a convertible loan
FTSE 100 closes ahead as US earnings season gets off to strong start
The UK blue-chip index closed up almost 23 points at 7,049 - up around 0.77% on the week as a whole
Archive
Proactive news snapshot: Cradle Arc, Hurricane Energy, Corero Network Security...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Hemogenyx teams up with Johnson & Johnson to develop new lupus treatment
Hemogenyx is to build a humanised mouse model of the lupus disease, which scientists will then use to help develop a new treatment
Investments and investor services
FTSE 100 closes positively as PM Theresa May says gov't is working towards a good Brexit deal
Britain's blue-chip benchmark finished up around 31 points at 7,029
HemoGenyx optimistic on CDX antibodies prospects
HemoGenyx said it was pleased with the opportunities that had been unlocked for its CDX antibodies during the first half
Well-received interim results boost Biome Technologies and Gamma Communications
A look at some of the biggest risers and fallers in London on Monday
Archive
Proactive news snapshot: Hurricane Energy, SkinBioTherapeutics, Tissue Regenix …
A glance at some of the day's highlights from the Proactive Investors newswire
FTSE 100 sails higher, bolstered by stumbling sterling
The UK blue-chip index finished up over 72 points at 7,504, while the mid-cap FTSE 250 was also higher
Archive
Proactive news snapshot: Papua Mining, Midatech Pharma, Sound Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Redcentric shares slip as it downgrades outlook for 2019
A look at some of the biggest risers and fallers in London on Friday
FTSE 100 closes lower on day and week after lacklustre trading; miners weigh
Footsie closed out down around 23 points at 7,681 and was also down on the week as a whole, off around 0.26%
Archive
Proactive news snapshot: HemoGenyx Pharmaceuticals, Harvest Minerals, Touchstone Exploration …
A glance at some of the day's highlights from the Proactive Investors newswire
MTI Wireless shares fall as it reports decrease in revenues and profit
A look at some of the top risers and fallers in London on Monday
Investments and investor services
Hemogenyx teams up with global pharma company to help further develop CDX antibodies
Hemogenyx will now have access to free technical support and advanced methods of engineering which should aid development of its flagship CDX antibodies
FTSE 100 closes in red as there is little around to spark investor interest
FTSE 250 fared better though closing ahead by around 15 points at 20,800.
Archive
Proactive news snapshot: Challenger Acquisitions, SDX Energy, Greencoat UK Wind …
A glance at some of the day's highlights from the Proactive Investors newswire
Nanoco Group on the front foot after receiving £1.8mln payment from US partner
A look at some of the top risers and fallers in London on Tuesday
Investments and investor services
HemoGenyx signs collaboration agreement with Rockefeller University to develop new Lupus treatments
Vladislav Sandler, CEO and co-founder of HemoGenyx, said: “This agreement with Rockefeller has the potential to extend our product candidate opportunities into a new and exciting area, and we would fully expect to see the work funded throug
FTSE 100 closes slightly in red; Shire biggest gainer
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
Proactive news snapshot: OptiBiotix Health, Kromek Group, Union Jack Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Cora Gold leads small cap risers as it boasts “exciting high grade results”
A look at some of the biggest risers and fallers in London on Tuesday.